杭州凡末科技有限公司入驻未来科技城(海创园)
Jiang Nan Shi Bao·2025-10-20 07:52

Core Insights - Hangzhou Fanmo Technology Co., Ltd. has signed an agreement to settle in Hangzhou Future Science and Technology City, aiming to transition from a startup to a national high-tech enterprise within five years [1] - The company will utilize a 80㎡ research and office space, focusing on three main areas: intelligent health streaming media, AI graphics, and medical data processing [1] - Fanmo Technology plans to establish a research team of at least 20 members within the next twelve months, with a minimum of 60% holding master's or doctoral degrees [1] Financial and Policy Support - The agreement includes a comprehensive support package from Hangzhou Xukun Entrepreneurship Service Co., Ltd., which offers 100% rent subsidy for the first three years and 50% for the following two years [1] - Newly recruited doctoral graduates will receive a living subsidy of 100,000 yuan, with additional incentives for long-term insurance and rewards for graduates from top 100 QS universities [1] - High-level talents from abroad can receive up to 1 million yuan in relocation subsidies, along with benefits for children's education and medical care [1] Company Development Goals - Since its establishment in February 2025, the company has developed four software copyrights and filed three patents in the AI and medical information sector [1] - The company anticipates that R&D investment will exceed 50% of its revenue by 2025, meeting the core criteria for national high-tech enterprise recognition [1] - The goal is to achieve national high-tech enterprise certification by 2030, positioning the science park as a launchpad for capital market entry [1] Industry Context - The entry of Fanmo Technology into the science park is expected to leverage the innovation and industrial incubation advantages of Yuhang District, combined with the policy benefits of the Hangzhou West Science and Technology Corridor [1] - Industry analysts believe that the company is likely to achieve significant breakthroughs within five years due to this strategic positioning [1]